青光眼诊断与治疗的进展：整合创新以改善患者预后
Advances in Glaucoma Diagnosis and Treatment: Integrating Innovations for Enhanced Patient Outcomes.
作者信息
Hung Shih-Heng, Yen Wei-Ting, Lu Da-Wen
机构信息
Department of General Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
出版信息
Biomedicines. 2025 Apr 2;13(4):850. doi: 10.3390/biomedicines13040850.
Abstract
Glaucoma, a chronic and progressive eye disease, is a significant public health concern responsible for a substantial proportion of global vision impairment and blindness [...].
摘要
青光眼是一种慢性进行性眼病，是一个重大的公共卫生问题，在全球视力损害和失明病例中占相当大的比例[……]
相似文献
1
Advances in Glaucoma Diagnosis and Treatment: Integrating Innovations for Enhanced Patient Outcomes.青光眼诊断与治疗的进展：整合创新以改善患者预后
Biomedicines. 2025 Apr 2;13(4):850. doi: 10.3390/biomedicines13040850.
2
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.全球失明和远距离视力损伤原因 1990-2020：系统回顾和荟萃分析。
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11.
3
International Vision Care: Issues and Approaches.国际视野保健：问题与方法。
Annu Rev Vis Sci. 2017 Sep 15;3:53-68. doi: 10.1146/annurev-vision-102016-061407.
4
Factors associated with vision-related quality of life among the adult population living in Nagorno Karabagh.居住在纳戈尔诺-卡拉巴赫的成年人口中与视力相关生活质量相关的因素。
Public Health. 2017 Dec;153:137-146. doi: 10.1016/j.puhe.2017.09.004. Epub 2017 Oct 16.
5
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势，以及与 VISION 2020：看见的权利相关的可避免盲的患病率：全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
6
7
Routine eye examinations for persons 20-64 years of age: an evidence-based analysis.20至64岁人群的常规眼部检查：一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(15):1-81. Epub 2006 Jul 1.
8
Current perspectives in tackling glaucoma blindness.应对青光眼致盲的当前观点。
Indian J Ophthalmol. 2025 Mar 1;73(Suppl 2):S189-S196. doi: 10.4103/IJO.IJO_3280_23. Epub 2025 Feb 21.
9
Determinants of blindness from glaucoma among patients receiving treatment: a retrospective cohort study in Enugu, Nigeria.接受治疗的青光眼患者失明的决定因素：尼日利亚埃努古的一项回顾性队列研究。
BMC Ophthalmol. 2025 Feb 17;25(1):78. doi: 10.1186/s12886-025-03911-5.
10
Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017.时间趋势、青光眼导致盲和视力丧失的关联和流行情况：基于 2017 年全球疾病负担研究的观察性数据分析。
BMJ Open. 2022 Jan 6;12(1):e053805. doi: 10.1136/bmjopen-2021-053805.
本文引用的文献
1
Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies.青光眼神经保护的进展：药理学策略与新兴技术
Pharmaceuticals (Basel). 2024 Sep 25;17(10):1261. doi: 10.3390/ph17101261.
2
Predicting Glaucoma Surgical Outcomes Using Neural Networks and Machine Learning on Electronic Health Records.利用电子健康记录中的神经网络和机器学习预测青光眼手术结果。
Transl Vis Sci Technol. 2024 Jun 3;13(6):15. doi: 10.1167/tvst.13.6.15.
3
The Application of Rho Kinase Inhibitors in the Management of Glaucoma.Rho 激酶抑制剂在青光眼治疗中的应用。
Int J Mol Sci. 2024 May 21;25(11):5576. doi: 10.3390/ijms25115576.
4
Artificial Intelligence in Anterior Chamber Evaluation: A Systematic Review and Meta-Analysis.人工智能在前房评估中的应用：系统评价和荟萃分析。
J Glaucoma. 2024 Sep 1;33(9):658-664. doi: 10.1097/IJG.0000000000002428. Epub 2024 May 16.
5
Efficacy and Safety of Rho Kinase Inhibitors vs. Beta-Blockers in Primary Open-Angle Glaucoma: A Systematic Review with Meta-Analysis.Rho激酶抑制剂与β受体阻滞剂治疗原发性开角型青光眼的疗效和安全性：一项系统评价与荟萃分析
J Clin Med. 2024 Mar 18;13(6):1747. doi: 10.3390/jcm13061747.
6
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments.解决青光眼的神经退行性变：机制、挑战和治疗方法。
Prog Retin Eye Res. 2024 May;100:101261. doi: 10.1016/j.preteyeres.2024.101261. Epub 2024 Mar 26.
7
Machine learning-assisted prediction of trabeculectomy outcomes among patients of juvenile glaucoma by using 5-year follow-up data.机器学习辅助预测青少年青光眼患者小梁切除术的 5 年随访结果。
Indian J Ophthalmol. 2024 Jul 1;72(7):987-993. doi: 10.4103/IJO.IJO_2009_23. Epub 2024 Mar 8.
8
Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension.曲伏前列素眼内植入剂治疗开角型青光眼或高眼压症患者的 3 期随机临床试验
Ophthalmology. 2024 Sep;131(9):1021-1032. doi: 10.1016/j.ophtha.2024.02.022. Epub 2024 Feb 27.
9
Advancing Glaucoma Care: Integrating Artificial Intelligence in Diagnosis, Management, and Progression Detection.青光眼护理进展：将人工智能整合到诊断、管理和病情进展检测中。
Bioengineering (Basel). 2024 Jan 26;11(2):122. doi: 10.3390/bioengineering11020122.
10
Continuous 24-hour intraocular pressure monitoring in normal Chinese adults using a novel contact lens sensor system.新型隐形眼镜传感器系统对中国正常成年人进行 24 小时连续眼压监测。
Br J Ophthalmol. 2024 Oct 22;108(11):1535-1542. doi: 10.1136/bjo-2023-323361.
Zotero 插件